Drug intelligence / Profile preview

6-benzylguanine

Development stage
Phase 3
Modality
Small Molecules
Administration
Intravenous (used Clinically)
01

Overview

6-benzylguanine is a synthetic guanine analogue and small molecule antineoplastic agent. It acts as an irreversible inhibitor of the DNA repair enzyme O6-alkylguanine-DNA alkyltransferase (AGT), also known as methylguanine DNA methyltransferase (MGMT). By transferring its benzyl group to the active-site cysteine of AGT, it inactivates the enzyme, thereby preventing AGT-mediated repair of alkylated DNA lesions. This inhibition sensitizes tumor cells to alkylating agents such as temozolomide and carmustine by blocking their primary resistance mechanism. Clinically, it has been investigated primarily in combination with alkylating chemotherapy for glioblastoma and other solid tumors but was found to increase toxicity without significant benefit when combined with temozolomide. It is also widely used as a biochemical tool in research on DNA repair mechanisms[1][3][5][9].

Other names
6-(benzyloxy)-7H-purin-2-aMine6-benzyloxy guanineO6-BenzyLO-6-BenzyLO 6-BenzyL
02

Targets

AGT (O6-methylguanine-DNA methyltransferase)

Beyond the preview

Go deeper on 6-benzylguanine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 6-benzylguanine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call